SonoThera, a South San Francisco, CA-based biotechnology firm, raised $60.75M in Collection A funding.
The spherical was led by ARCH Enterprise Companions, with participation from Illumina Ventures, Johnson & Johnson Innovation, JJDC, Vertex Ventures HC, and Medical Excellence Capital Eli Lilly & Firm, Alexandria Enterprise Investments, Lifespan Investments, Formic Ventures, Foothill Ventures, and Wilson Sonsini.
The corporate intends to make use of the funds to assist the continued growth of its ultrasound-guided, nonviral, gene remedy platform and coverings, designed to offer sufferers with genetic medicines.
Based by Drs. Kenneth Greenberg, Michael Davidson, and Steve Feinstein, SonoThera is a biotechnology firm devoted to treating the basis explanation for human illness by genetic remedy. It’s creating an ultrasound-guided, nonviral gene remedy platform and coverings designed to offer sufferers with the subsequent era of protected and efficient genetic medicines. The platform makes use of sonoporation, a microbubble-mediated biophysical course of to non-invasively ship genetic payloads selectively focusing on a variety of organs inside the physique.